Skip to main content
Clinical Trials/NCT02090218
NCT02090218
Terminated
Not Applicable

I-Gel Versus Current Practice in Out-of-hospital Cardiac Arrest by Paramedics in Norway - a Prospective Stepped Wedge Crossover Trial

Haukeland University Hospital4 sites in 1 country550 target enrollmentFebruary 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Out of Hospital Cardiac Arrest
Sponsor
Haukeland University Hospital
Enrollment
550
Locations
4
Primary Endpoint
ventilation success
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

The main objective of this trial is to compare the effectiveness of a newer supraglottic airway method (the i-Gel), compared to current airway management practice in out-of-hospital cardiac arrests treated by Norwegian ambulance services.

Registry
clinicaltrials.gov
Start Date
February 2014
End Date
June 2016
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Haukeland University Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Out-of-hospital cardiac arrest patients requiring and receiving advanced airway management on ambulance missions. Advanced airway management is defined as the attempted insertion of an airway adjunct (I-Gel, laryngeal tube or ETI) or the administration of ventilatory assistance/support (including bag-mask ventilation (BMV) or other ventilatory support.
  • Adult patients (\> 18 years).

Exclusion Criteria

  • Non-adult patients / minors (\< 18 years).
  • Traumatic cardiac arrest.

Outcomes

Primary Outcomes

ventilation success

Time Frame: up to 24 hours

ventilation success defined as successful insertion of device with visible chest movement with each ventilation, audible air passage on auscultation, and ETCO2 confirmation (if available) of tube placement

Secondary Outcomes

  • survival to hospital discharge / 30-day survival(up to 30 days)
  • insertion related complications(up to 24 hours)
  • cerebral function assessed by Glascow Outcome Score at discharge from hospital(participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • levels of ETCO2 related to the presence and quality of bystander CPR(up to 24 hours)

Study Sites (4)

Loading locations...

Similar Trials